Pharma news
Refine search
Americas
The chair of the FTC has said it will continue to challenge pay-for-delay court settlements in the pharmaceutical industry and has hailed a Supreme Court ruling as a victory for consumers. 25 July 2013
Americas
Senator Patrick Leahy has urged the US National Institutes of Health to force Myriad Genetics to license its patents directed to tests for breast and ovarian cancer. 19 July 2013
Asia
India’s Intellectual Property Appellate Board has affirmed that US agricultural company Monsanto cannot obtain a patent covering transgenic plants, two years after it was first rejected. 15 July 2013
Americas
Belgian pharmaceutical company UCB SA has sued drug-maker Teva Pharmaceutical Industries to stop it manufacturing a generic version of epilepsy drug Vimpat. 3 July 2013
Americas
Pharmaceutical company AbbVie has won a patent case against UK research body The Kennedy Institute of Rheumatology Trust relating to the arthritis medication Humira. 2 July 2013
Asia
Pharmaceutical company Merck has secured a preliminary injunction against Indian drug company Aprica after it tried to market generic versions of the branded diabetes drug Januvia. 25 June 2013
Pharma
Global drug companies Actavis and Teva both launched generic versions of Viagra immediately after its patent expired in several European countries last week. 24 June 2013
Americas
The US Court of Appeals for the Federal Circuit concluded on June 18 that Novo Nordisk’s patent covering diabetes treatment repaglinide is invalid. 21 June 2013
Pharma
The European Commission’s competition directorate has levied fines totalling €146 million ($195 million) against originator pharmaceutical company Lundbeck and several producers of generics drugs. 20 June 2013
Americas
A majority of the US Supreme Court has ruled that the US Federal Trade Commission should be able to challenge so-called ‘pay-for-delay’ patent litigation settlements on antitrust grounds. 17 June 2013